CoChat

Practical utility of amyloid and FDG-PET in an academic dementia center

Open access
Sánchez-Juan, Pascual, Ghosh, Pia M., Hagen, Jayne, Gesierich, Benno, Henry, Maya, Grinberg, Lea T., O'Neil, James P., Janabi, Mustafa, Huang, Eric J., Trojanowski, John Q., Vinters, Harry V., Gorno-Tempini, Marilu, Seeley, William W., Boxer, Adam L., Rosen, Howard J., Kramer, Joel H., Miller, Bruce L., Jagust, William J., Rabinovici, Gil D. · 2014 · Neurology
Cited by 78

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To evaluate the effect of amyloid imaging on clinical decision making. METHODS: We conducted a retrospective analysis of 140 cognitively impaired patients (mean age 65.0 years, 46% primary β-amyloid (Aβ) diagnosis, mean Mini-Mental State Examination 22.3) who underwent amyloid (Pittsburgh compound B [PiB]) PET as part of observational research studies and were evaluated clinically before and after the scan. One hundred thirty-four concurrently underwent fluorodeoxyglucose (FDG)-PET. We assessed for changes between the pre- and post-PET clinical diagnosis (from Aβ to non-Aβ diagnosis or vice versa) and Alzheimer disease treatment plan. The association between PiB/FDG results and changes in management was evaluated using χ(2) and multivariate logistic regression. Postmortem diagnosis was available for 24 patients (17%). RESULTS: Concordance between scan results and baseline diagnosis was high (PiB 84%, FDG 82%). The primary diagnosis changed after PET in 13/140 patients (9%) overall but in 5/13 (38%) patients considered pre-PET diagnostic dilemmas. When examined independently, discordant PiB and discordant FDG were both associated with diagnostic change (unadjusted p < 0.0001). However, when examined together in a multivariate logistic regression, only discordant PiB remained significant (adjusted p = 0.00013). Changes in treatment were associated with discordant PiB in patients with non-Aβ diagnoses (adjusted p = 0.028), while FDG had no effect on therapy. Both PiB (96%) and FDG (91%) showed high agreement with autopsy diagnosis. CONCLUSIONS: PET had a moderate effect on clinical outcomes. Discordant PiB had a greater effect than discordant FDG, and influence on diagnosis was greater than on treatment. Prospective studies are needed to better characterize the clinical role of amyloid PET.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000000032

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 78

Metadata

Authors
Sánchez-Juan, P., Ghosh, P. M., Hagen, J., Gesierich, B., Henry, M., Grinberg, L. T., O'Neil, J. P., Janabi, M., Huang, E. J., Trojanowski, J. Q., Vinters, H. V., Gorno-Tempini, M., Seeley, W. W., Boxer, A. L., Rosen, H. J., Kramer, J. H., Miller, B. L., Jagust, W. J., & Rabinovici, G. D.
Venue
Neurology
Published
2014-01-21
Volume
82
Issue
3
Pages
230-238
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2086247600
Cited by
78
References
16
FWCI
6.59
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Practical utility of amyloid and FDG-PET in an academic dementia center. https://app.cochat.ai/papers/10.1212/wnl.0000000000000032
The paper
Sánchez-Juan, P., Ghosh, P. M., Hagen, J., Gesierich, B., Henry, M., Grinberg, L. T., O'Neil, J. P., Janabi, M., Huang, E. J., Trojanowski, J. Q., Vinters, H. V., Gorno-Tempini, M., Seeley, W. W., Boxer, A. L., Rosen, H. J., Kramer, J. H., Miller, B. L., Jagust, W. J., & Rabinovici, G. D. (2014). Practical utility of amyloid and FDG-PET in an academic dementia center. Neurology. https://doi.org/10.1212/wnl.0000000000000032

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.